Skip to main content
. 2017 Jun 27;174(15):2528–2544. doi: 10.1111/bph.13865

Figure 8.

Figure 8

Antinociceptive effects of μ‐TRTX‐Df1a. (A) Intraplantar injection of the NaV1.7 activator OD1 (300 nM) led to rapid development of nocifensive behaviour in mice. This spontaneous pain behaviour, measured by the number of paw licks and flinches, was attenuated in a concentration‐dependent manner by co‐administration of sDf1a‐OH at 1 and 10 μM, and sDf1a‐NH2 at 10 μM but not at 1 μM. Data are presented as mean ± SEM of n = 5 mice per group treated with Df1a and n = 12 mice in the control group. *P < 0.05.